Gilead's increase of HIV drugs price unreasonable, says AHF

Links shared publicly online about this topic.

388
total visits

Gilead's increase of HIV drugs price unreasonable, says AHF

Today AIDS Healthcare Foundation (AHF), the largest global AIDS organization, blasted the news that Gilead Sciences Inc. increased the prices of several of its top selling products at the beginning of the month. The California-based drug maker increased the price of its biggest seller, HIV treatment Atripla, by 5.1%. Gilead also raised the price of HIV drugs Truvada and Emtriva by 7.9%.

View full resource at news-medical.net

Tags: HIV, HIV Medication, STD, Drug, Health Insurance, Medicare, News